BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 10557064)

  • 21. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells.
    Weerasinghe P; Hallock S; Tang SC; Trump B; Liepins A
    Exp Toxicol Pathol; 2006 Aug; 58(1):21-30. PubMed ID: 16735106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L
    Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
    Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines.
    Legdeur MC; Bontje PM; Ossenkoppele GJ; Beelen RH; van de Loosdrecht AA; Broekhoven MG; Langenhuijsen MM; Thijsen SF; Hofstee H; Schuurhuis GJ
    Exp Hematol; 1996 Nov; 24(13):1530-9. PubMed ID: 8950237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.
    Den Boer ML; Zwaan CM; Pieters R; Kazemier KM; Rottier MM; Flens MJ; Scheper RJ; Veerman AJ
    Leukemia; 1997 Jul; 11(7):1078-85. PubMed ID: 9204995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
    Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
    Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methadone hydrochloride and leukemia cells: Effects on cell viability, DNA fragmentation and apoptotic proteins expression level.
    Kua VMD; Rasul A; Sreenivasan S; Rasool B; Younis T; Lai NS
    Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1797-1803. PubMed ID: 31680075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
    Li DQ; Wang ZB; Bai J; Zhao J; Wang Y; Hu K; Du YH
    World J Gastroenterol; 2004 Jun; 10(12):1722-5. PubMed ID: 15188493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.
    Majlessipour F; Kwock R; Martin-Aragon S; Weinberg KI; Avramis VI
    Anticancer Res; 2001; 21(1A):11-22. PubMed ID: 11299723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
    Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B; Safa AR
    Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates.
    Messingerova L; Imrichova D; Kavcova H; Turakova K; Breier A; Sulova Z
    Toxicol In Vitro; 2015 Oct; 29(7):1405-15. PubMed ID: 26009263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42.
    Moran E; Cleary I; Larkin AM; Amhlaoibh RN; Masterson A; Scheper RJ; Izquierdo MA; Center M; O'Sullivan F; Clynes M
    Eur J Cancer; 1997 Apr; 33(4):652-60. PubMed ID: 9274450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic Effect of Baicalin and Adriamycin in Resistant HL-60/ADM Leukaemia Cells.
    Zheng J; Asakawa T; Chen Y; Zheng Z; Chen B; Lin M; Liu T; Hu J
    Cell Physiol Biochem; 2017; 43(1):419-430. PubMed ID: 28869936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F; Avramis IA; Kwock R; Weinberg KI; Avrami VI
    Anticancer Res; 2002; 22(3):1361-8. PubMed ID: 12168812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.
    Ohi Y; Kim R; Toge T
    Int J Oncol; 2000 May; 16(5):959-69. PubMed ID: 10762632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Loop' domain deletional mutant of Bcl-xL is as effective as p29Bcl-xL in inhibiting radiation-induced cytosolic accumulation of cytochrome c (cyt c), caspase-3 activity, and apoptosis.
    Burri SH; Kim CN; Fang G; Chang BS; Perkins C; Harris W; Davis LW; Thompson CB; Bhalla KN
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):423-30. PubMed ID: 10030271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
    Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT
    Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.